Tirzepatide is made by pharmaceutical company Eli Lilly, which is providing the drugs for the long COVID trial
Is your site currently positioned to support obesity and metabolic disease trials
Arnott C, Li Q, Kang A, Neuen BL, Bompoint S, Lam CSP, et al
The problem is that zero clinical trials have tested whether this translates to fewer side effects or equivalent weight loss
As this long-acting amylin analogue advances through Phase 3 clinical trials, having a comprehensive reference for proper administration protocols has never been more critical
Muscle mass decreases at an accelerating rate, a process called sarcopenia, and since muscle tissue burns more calories than fat tissue, this compounds the metabolic slowdown